Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines
Theron Gilliland, Yanan Liu, Rong Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22

Showing 22 citing articles:

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 589
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 245
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Ryuta Uraki, Peter Halfmann, Shun Iida, et al.
Nature (2022) Vol. 612, Iss. 7940, pp. 540-545
Open Access | Times Cited: 86
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
Michael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 85
Experimental Models of COVID-19
Luis A. Caldera-Crespo, Michael J. Paidas, Sabita Roy, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 39
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Ryuta Uraki, Shun Iida, Peter Halfmann, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2
Joseph W. Golden, Rong Li, Curtis R. Cline, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 26
Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus
Shikun Ge, Rao Wu, Tingting Zhou, et al.
AMB Express (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Transchromosomic bovines‐derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS‐CoV‐2, MERS‐CoV, Ebola, Zika, HIV‐1, and influenza A virus
AbdulRahman A. Saied, Manuela Sales Lima Nascimento, Adriano Henrique do Nascimento Rangel, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4599-4610
Open Access | Times Cited: 10
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Ryuta Uraki, Shun Iida, Peter Halfmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
Bernard Vanhove, Stéphane Marot, Ray T. Y. So, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models
Yu Cong, Ji Hyun Lee, Donna L. Perry, et al.
Antiviral Research (2023) Vol. 214, pp. 105605-105605
Open Access | Times Cited: 2
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates
Yoshihiro Kawaoka, Ryuta Uraki, Peter Halfmann, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
Bernard Vanhove, Stéphane Marot, Ray T. Y. So, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model
Douglas S. Reed, Anita K. McElroy, Dominique J. Barbeau, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0290909-e0290909
Open Access
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, et al.
Antibodies (2023) Vol. 12, Iss. 2, pp. 33-33
Open Access | Times Cited: 1
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries
Marcelo Alves Pinto, Alexandre dos Santos da Silva, Daniela del Rosário Flores Rodrigues, et al.
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 1
No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model
Douglas S. Reed, Anita K. McElroy, Dominique J. Barbeau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Is There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19?
Sohail Rao, Caitlin White, Manish Singh
DHR Proceedings (2021) Vol. 1, Iss. S5, pp. 1-3
Closed Access
Page 1

Scroll to top